Search

You searched for "Belfast"

253 results found

Enter the Dragons’ Den: Bob Gokani

4 December 2024 | | EYE - General
I have often daydreamed about inventing a successful new product and then going on to pitch for investment on Dragons’ Den, with the TV show’s seasoned entrepreneurs all competing with each other to invest in my company. My imagined fantasy...

Poppers retinopathy: What is it and how do we treat it?

2 June 2025 | | EYE - Vitreo-Retinal
Poppers retinopathy is a relatively unknown phenomenon which afflicts users of poppers but should be considered as a differential in sudden-onset or sub-acute visual acuity loss – particularly in patients with a history of recreational drug use. Raising awareness of...

What's trending Feb/Mar 2018

1 February 2018 | | EYE - General
A round-up of the eye related hot topics that have been trending on social media over the last few weeks. We are officially in 2018. New year, new you. The clock starts to turn to midnight and suddenly the excess...

Hype or helpful: ChatGPT

5 June 2023 | | EYE - General
It would have been hard to miss all the attention chatbots have received over the last few months. Whilst ChatGPT is easily the most well-known example of the large language models that have become so widespread of late, artificial intelligence...

Record rise in competition ratios for ophthalmology: What does this mean for the future of the ophthalmology training programme?

2 October 2025 | | EYE - General
In this article, Adina Smith discusses factors likely to contribute to the record rise in competition ratios and the impact this may have on the future of OST. Ophthalmology specialty training (OST) is the fifth most competitive training programme in...

Competition ratios: Is the future of ophthalmology too bright?

29 August 2023 | | EYE - General
In the UK, ophthalmology is a highly competitive speciality, attracting many medical graduates keen to pursue a career in this area. However, in recent years, the competition ratios for ophthalmology ST1 training posts have increased significantly, creating a challenging environment...

Evolving towards an interventional glaucoma mindset

2 February 2024 | | EYE - Glaucoma
Traditionally, a newly diagnosed glaucoma patient would be treated first with medical therapy. As the disease progressed or the initial intervention failed to adequately control intraocular pressure (IOP), clinicians would add more drops, selective laser trabeculoplasty (SLT), repeated SLT and...

A Nightmare on Doctor Street

3 October 2022 | | EYE - General
“Number one: you can never have sex. Big no no! Big no no! Sex equals death, okay?Number two: you can never drink or do drugs. The sin factor! It’s a sin. It’s an extension of number one.And number three: never,...

Aspiration of anteriorly migrated dexamethasone implant using an 18G intravenous cannula

4 December 2025 | | EYE - Cornea, EYE - Vitreo-Retinal
Intravitreal dexamethasone (Ozurdex 0.7mg) is a biodegradable, sustained-release implant used to manage diabetic macular oedema, macular oedema secondary to retinal vein occlusion, and non-infectious posterior uveitis due to its anti-inflammatory effects and VEGF suppression [1]. While effective, the implant may...

Pathophysiology of diabetic macular oedema: why combination therapy may be better

1 October 2015 | | EYE - Vitreo-Retinal
The prevalence of diabetes has continued to increase over the years. It is currently estimated that there are 382 million with diabetes worldwide in 2013, and that this figure is expected to rise to 592 million by 2035 [1]. In...

NICE drugs: an update on what’s good to go

1 June 2014 | | EYE - Neuro-ophthalmology, EYE - Vitreo-Retinal
Treatment options recommended by the National Institute for Health and Care Excellence (NICE) must be readily available for use in the NHS of England and Wales. This article provides an overview of recent guidance from NICE and summary advice issued...

Treatment of diabetic macular oedema

1 June 2014 | | EYE - Vitreo-Retinal
Diabetic macular oedema (DMO) is a common complication associated with diabetic retinopathy, and the most common cause of visual impairment in diabetes [1]. With predicted rising levels of diabetes (in England by 2025 the estimated population with diabetes will be...